Cross‐company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group
Timothé Ménard, Kyle Young, Laura Siegel, Jennifer Emerson, Robert Studt, Leslie Sidor, The IMPALA Industry Group
Abstract
Quality functions from pharmaceutical sponsor companies aim to increase the use of analytics in their oversight of Good Clinical Practices and Pharmacovigilance activities. To leverage and accelerate progress, several companies decided to establish a collaborative model. The goals of this collaboration span the sharing of knowledge and ideas, the sharing of analytics methods, discussion of talent upskilling and technology adoption strategies, and collaborative discussion on these potential changes with global Health Authorities.
Topics & Concepts
Leverage (statistics)AnalyticsBusinessPharmacovigilanceKnowledge managementQuality (philosophy)Pharmaceutical industryData scienceComputer scienceDrugPharmacologyMedicineEpistemologyMachine learningPhilosophyBiosimilars and Bioanalytical MethodsPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life